Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acorda Therapeutics (ACOR)
NASDAQ:ACOR
Holding ACOR?
Track your performance easily
ACOR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.25 - $24.18
Previous Close$0.44
Volume416.93K
Average Volume (3M)134.46K
Market Cap
$546.52K
Enterprise Value$161.46M
Total Cash (Recent Filing)$29.98M
Total Debt (Recent Filing)$190.90M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
May 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-254.34
Shares Outstanding1,242,098
10 Day Avg. Volume785,337
30 Day Avg. Volume134,459
Standard Deviation0.42
R-Squared0.03
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.00500
Price to Sales (P/S)0.02
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.37
Enterprise Value/Gross Profit1.58
Enterprise Value/Ebitda-0.76
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Acorda Therapeutics News
PremiumCompany Announcements
Acorda Therapeutics’ Strategic Bankruptcy and Asset Sale PlanRisk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACOR FAQ
What was Acorda Therapeutics’s price range in the past 12 months?
Acorda Therapeutics lowest stock price was $0.25 and its highest was $24.18 in the past 12 months.
What is Acorda Therapeutics’s market cap?
Currently, no data Available
When is Acorda Therapeutics’s upcoming earnings report date?
Acorda Therapeutics’s upcoming earnings report date is May 08, 2024 which is 135 days ago.
How were Acorda Therapeutics’s earnings last quarter?
Acorda Therapeutics released its earnings results on Apr 01, 2024. The company reported -$225.805 earnings per share for the quarter, missing the consensus estimate of N/A by -$225.805.
Is Acorda Therapeutics overvalued?
According to Wall Street analysts Acorda Therapeutics’s price is currently Overvalued.
Does Acorda Therapeutics pay dividends?
Acorda Therapeutics does not currently pay dividends.
What is Acorda Therapeutics’s EPS estimate?
Acorda Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acorda Therapeutics have?
Acorda Therapeutics has 1,242,098 shares outstanding.
What happened to Acorda Therapeutics’s price movement after its last earnings report?
Acorda Therapeutics reported an EPS of -$225.805 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -81.44%.
Which hedge fund is a major shareholder of Acorda Therapeutics?
Among the largest hedge funds holding Acorda Therapeutics’s share is Canyon Capital Advisors LLC. It holds Acorda Therapeutics’s shares valued at N/A.
---
Acorda Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
ACOR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-95.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-73.16%
Trailing 12-Months
Company Description
Acorda Therapeutics
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.
---
ACOR Company Deck
---
ACOR Earnings Call
Q3 2023
0:00 / 0:00
---
ACOR Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---